What is the recommended dose of Doripenem (doripenem) for patients with impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doripenem Dosing in Renal Impairment

For patients with impaired renal function, doripenem 250 mg every 8 hours (infused over 1 hour) is recommended for creatinine clearance 30-50 mL/min, and 250 mg every 12 hours for creatinine clearance 10-29 mL/min. 1

Standard Dosing in Normal Renal Function

For critically ill patients with normal renal function (CrCl >90 mL/min), the standard dose is doripenem 500 mg every 8 hours for intra-abdominal infections and serious gram-negative infections. 1

Renal Impairment Dosing Adjustments

Moderate Renal Impairment (CrCl 30-50 mL/min)

  • Dose: 250 mg every 8 hours infused over 1 hour 2
  • This regimen maintains adequate pharmacokinetic/pharmacodynamic targets for pathogens with MICs ≤2 mg/L 2

Severe Renal Impairment (CrCl 10-29 mL/min)

  • Dose: 250 mg every 12 hours infused over 1 hour 2
  • Extended infusion over 4 hours can be considered to improve target attainment for organisms with higher MICs (up to 4 mg/L) 2

Continuous Renal Replacement Therapy (CRRT)

For critically ill patients receiving continuous venovenous hemodiafiltration or hemodialysis:

  • Recommended dose: 1 gram every 8 hours 3
  • A loading dose of 1.5-2 grams may be considered for critically ill septic patients 3
  • The original 500 mg every 8 hours recommendation was based on non-septic patients and may be inadequate for critically ill septic patients 3
  • CVVHDF clearance accounts for approximately 30-37% of total doripenem clearance 4
  • Mean hemofilter clearance is approximately 36.53 mL/min with steady-state trough levels around 8.5 mg/L 3

Important CRRT Considerations

  • Doripenem clearance during CVVHDF correlates significantly with replacement fluid flow rate 4
  • The 500 mg every 8 hours dose achieves favorable pharmacokinetics for MICs up to 4 mg/L in standard CVVHDF settings (blood flow 200 mL/h, dialysate 1000 mL/h, replacement fluid 1000 mL/h) 4
  • However, for septic patients with higher severity of illness, the 1 gram every 8 hours regimen is preferred 3

Optimizing Doripenem Efficacy

Extended Infusion Strategy

  • 4-hour infusions improve target attainment compared to 1-hour infusions 2
  • Extended infusions allow adequate coverage for pathogens with MICs up to 4 mg/L, even in patients with normal renal function 2
  • This strategy is particularly valuable when treating infections with less susceptible organisms 2

Pharmacodynamic Targets

  • Doripenem efficacy correlates with time above MIC (T>MIC) of 35% of the dosing interval 2, 5
  • For patients with CrCl >50 mL/min receiving 500 mg every 8 hours as 1-hour infusion: adequate for MICs ≤1 mg/L 2
  • Same dose as 4-hour infusion: adequate for MICs ≤4 mg/L 2

Critical Clinical Pearls

Avoid underdosing in CRRT patients: The updated recommendation of 1 gram every 8 hours for CRRT patients reflects recognition that critically ill septic patients require higher doses than the original 500 mg recommendation, which was based on non-septic populations. 3

Monitor for accumulation: While doripenem does not show considerable accumulation at steady state in CRRT patients, individual pharmacokinetic variability exists, particularly related to replacement fluid flow rates. 4, 3

Consider pathogen MIC: Dosing decisions should account for the suspected or documented MIC of the infecting organism, with extended infusions preferred when MICs approach 2-4 mg/L. 2, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.